CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K Reporting owner sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Parsey Merdad Director | Grant or award | +26,455 | 83,746 | ||
| 2026-06-16 | Parsey Merdad Director | Grant or award · Stock Option (Right to Buy) | +39,715 | 39,715 | ||
| 2025-06-18 | Parsey Merdad Director | Grant or award | +15,235 | 57,291 | ||
| 2025-04-28 | Parsey Merdad Director | Grant or award | +42,056 | 42,056 | ||
| 2025-04-28 | Parsey Merdad Director | Grant or award · Stock Option (Right to Buy) | +64,457 | 64,457 |
Page 1 of 1 · 5 trades